Registered entities
Allogene Therapeutics, Inc.
Reg. No. 823562771United States
Social engagement
Social engagement: 80.2K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
17 investors on record; lead investors include Perceptive Advisors, Deerfield; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 29% |
| Private equity | 4 | 24% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 7 | 41% |
Hiring activity
Hires frequently
25 roles tracked across 6 of the last 12 months
14 May 2026 · Associate Director, Data Science · South San Francisco
14 May 2026 · Senior Counsel, Corporate, Securities & Transactions · South San Francisco
12 May 2026 · Calibration Technician · Newark
28 Apr 2026 · Director, Translational Operations · South San Francisco
24 Apr 2026 · Associate Director, Regulatory Affairs · South San Francisco
Based on job postings tracked across public sources.
Recent activity
25 Jun 2026
Product launch
AlloCAR T products
23 Jun 2026
Event
Full Endpoints News R&D 15 Session
19 Jun 2026
Product launch
ALLO-329